このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

肺線維症における異常グリコシル化:メカニズム,バイオマーカー,治療の可能性

  • 0Department of Thoracic Surgery II, Department of Lung Transplantation, Organ Transplantation Center, The First Hospital of Jilin University, Changchun, 130021, China.

まとめ

この要約は機械生成です。

関連する概念動画

Proteoglycans 01:05

4.0K

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...

Pulmonary Hypertension: Classification and Pathogenesis 01:30

285

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Cystic Fibrosis: Management 01:24

223

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...